Xiang Li

New insight into Alzheimer’s disease: small molecule-Aβ in the brain transport and peripheral organ clearance

Alzheimer’s disease (AD) represents one of the most prevalent neurodegenerative disorders without approved disease-modifying therapies. A major contributing factor is that, for decades, drug development has focused almost exclusively on repairing or removing lesions within the brain itself. Yet a growing body of work n...